Prevent Cancer Foundation welcomes 2025 corporate members advancing cancer prevention and early detection
POUR DIFFUSION IMMÉDIATE
Audrey Kashatus
703-836-3687
audrey.kashatus@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® proudly welcomes its largest-ever cohort—16 leading companies—as 2025 members of the Corporate Membership Program. These organizations join a growing community dedicated to advancing cancer prevention and early detection nationwide.
“In just two years, our Corporate Membership Program has grown into a thriving community of partners dedicated to cancer prevention and early detection,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “These corporate partners share our commitment to saving lives, and by collaborating with industry leaders, we’re reaching more people and helping them take charge of their health.”
The 2025 class of corporate members, as of the date of this publication, include:
Silver members
- Sciences exactes
- Hologique
- Ipsen
- Pfizer
- PhRMA
Bronze members
- AstraZeneca
- AVEO Oncology
- Amgen
- BMS
- Eisaï
- Genentech
- Geneoscopy
- Gardien
- Lilly
- Merck
- Natera
- Sanofi
Through the Corporate Membership Program, business leaders help expand the Foundation’s reach and impact. Members participate in Foundation events, including industry roundtables, to collaborate and exchange ideas throughout the year. Membership supports the Foundation’s work in four key areas: research, education, outreach and advocacy.
The Corporate Membership Program is open to companies who share the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. To learn more or inquire about joining, contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.
###
About the Prevent Cancer Foundation®
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous nous engageons à investir $20 millions dans des technologies innovantes pour détecter le cancer à un stade précoce et faire progresser le dépistage multi-cancer, $10 millions pour étendre le dépistage du cancer et la vaccination. l'accès à des communautés médicalement mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.
For more information, please visit www.preventcancer.org.